Intron Biotechnology Inc. | Ownership
Companies that own Intron Biotechnology Inc.
Mirae Asset Global Investments Co., Ltd.
945,176
6.29%
184,002
0.28%
04/28/2017
National Pension Service of Korea
806,626
5.36%
181,943
0.02%
01/16/2018
The Vanguard Group, Inc.
262,239
1.74%
16
0%
07/31/2018
BlackRock Fund Advisors
184,357
1.23%
0
0%
09/05/2018
BlackRock Advisors (UK) Ltd.
155,135
1.03%
0
0%
09/06/2018
Manulife Asset Management (Hong Kong) Ltd.
70,000
0.47%
70,000
0.06%
12/31/2017
Baillie Gifford & Co.
41,921
0.28%
0
0%
10/31/2017
Norges Bank Investment Management
20,485
0.14%
-99,100
0%
12/31/2017
Charles Schwab Investment Management, Inc.
17,947
0.12%
0
0%
09/06/2018
SSgA Funds Management, Inc.
7,911
0.05%
0
0%
09/06/2018
| Address |
Unit 701-704, Joong-Ang Induspia
Seongnam-si GY 13202
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.intron.co.kr |
| Updated |
09/14/2018 |
| iNtRON Biotechnology, Inc. engages in the development of super-bacteria treatment, antibiotics alternatives, bio new drug, molecular diagnostics and artificial blood. Its products include anti-bacterial agents, identification kits, research reagents and kits. The company was founded on January 18, 1999 and is headquartered in Seongnam-si, South Korea. |
